<\/div><\/aside>\n

Dr. Marty Makary has resigned as Food and Drug Management (FDA) commissioner, effective Tuesday, according to Politico and ABC News. The report says the decision followed policy disagreements with President Donald Trump and certain Republican senators, and also involved multiple long-simmering issues inside the agency.<\/p>\n

The outgoing and incoming leadership change is expected to be handled by Kyle Diamantas, who will lead the FDA in an acting capacity. Makary\u2019s resignation is described by supporters and critics alike as tied to his regulatory decisions and perceived responses to the administration\u2019s priorities-particularly around telehealth access to the abortion pill mifepristone<\/a>, and the FDA\u2019s treatment of flavored vaping products. The article also notes criticism from biopharmaceutical companies regarding consistency in how the FDA reviews their medicines, and mentions pediatric and advocacy concerns about flavored e-cigarettes<\/a> for minors. <\/p>\n